Agenda

The Symposium will be held virtually from 9:30 – 17:00 CET

9.20-9.30 – Welcoming (Alessia Ligresti and Marialessandra Contino)
Chairs: Marialessandra Contino and Maria Laura Bolognesi

9.30 – Prof. Michael Decker (University of Würzburg)
Neuroprotective strategies for Alzheimer's disease drug development

10.00 – Prof. Mauro Maccarrone (University of L’Aquila)
A biochemical perspective on the interaction between endocannabinoids and other bioactive lipids in neuroinflammation

10.30 – Dr. Brendan Hughes (European Union Drugs Agency)
An international regulatory perspective on cannabis and cannabinoids

11.00-12.00 – Round table: discussion forum

BREAK

14.20-14.30 – Introducing Alessia Ligresti and Marialessandra Contino
Chairs: Alessia Ligresti and Miriam Melis

14.30 – Prof. Vincenzo Di Marzo (University of Laval)
A biochemical and pharmacological perspective on the endocannabinoidome-gut microbiome axis

15.00 – Prof. Ester Aso (University of Barcelona)
A pharmacological perspective on the potential utility of natural cannabinoids against Alzheimer's disease

15.30 – Prof. Dr. Franjo Grotenhermen (Canncura GmbH)
A medical perspective on cannabinoids in skin diseases

16-17.00 – Round table: discussion forum

The Symposium will be held virtually from 9:30 – 17:00 CET

9.20-9.30 - Welcoming (Alessia Ligresti and Marialessandra Contino)

Alessia Ligresti and Manuel Guzman

9.30 - Prof. Laura Heitman (Leiden University)
A pharmacological perspective on cannabinoidrReceptor drug discovery - Adding kinetic context

10.00 - Prof. Cristina Sanchez (Complutense University of Madrid)
A biochemical perspective on the endocannabinoid system as a therapeutic tool in cancer progression

10.30 - Dr. Colin Stott (Phytanix Bio)
A regulatory perspective on the development of cannabis-based and cannabinoid medicines

11.00-12.00 - Round table: discussion forum

BREAK

14.20-14.30 - Introducing Alessia Ligresti and Marialessandra Contino
Marialessandra Contino and David Finn

14.30 - Prof. Nadine Jagerovic (Spanish National Research Council)
An academic medicinal chemistry perspective on the endocannabinoid system modulators

15.00 - Prof. Katarzyna Starowicz (Maj Institute of Pharmacology, PAS)
(Endo)cannabinoids as therapeutic option in chronic pain treatment

15.30 - Prof. Jose Martinez-Orgado (Hospital Clínico "San Carlos”)
A preclinical and clinical perspective on cannabinoids for newborn brain damage

16-17.00 - Round table: discussion forum

The Symposium will be held virtually from 9:30 – 17:00 CET

9.20-9.30 - Welcoming (Alessia Ligresti and Marialessandra Contino)

Alessia Ligresti and Raquel Peyraube

9.30 - Prof. Saoirse O’Sullivan (Artelo Biosciences)
Driving FABP inhibition to the clinic

10.00 - Prof. Andrea Chicca (Synendos Therapeutics)
A translational perspective on first-in-class selective endocannabinoid reuptake inhibitors: from basic research to clinical development

10.30 - Prof. Geoffrey Guy / Prof. Alistair Nunn (The Guy Foundation - GW Pharmaceuticals)
The possible non-pharmacological basis of cannabinoid effects on biological systems

11.00-12.00 - Round table: discussion forum

BREAK

14.20-14.30 - Introducing Alessia Ligresti and Marialessandra Contino
Marialessandra Contino and Maria Majellaro

14.30 - Dr. Uwe Grether (Roche)
A medicinal chemistry perspective on Cannabinoid Receptor Type 2 - Snapshots from a drug discovery program

15.00 - Dr. Hunter Land (Lupvindol Biosciences)
A Polypharmacological Perspective on Cannabinoid Based Therapies

15.30 - Prof. Dr. Kirsten R. Müller-Vahl (Hannover Medical School)
A clinical perspective on cannabinoids in psychiatry

16-17.00 - Round table: discussion forum